SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-119323
Filing Date
2024-11-14
Accepted
2024-11-14 17:48:35
Documents
2
Group Members
LENE SKOLE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427620d16_sc13ga.htm SC 13G/A 50839
2 EXHIBIT 1 tm2427620d16_ex1.htm EX-99.1 3615
  Complete submission text file 0001104659-24-119323.txt   56019
Mailing Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100
Business Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100 4540307375
Lundbeckfond Invest A/S (Filed by) CIK: 0001591046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90193 | Film No.: 241464770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)